These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 36416543

  • 1. Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial.
    Kangasniemi MH, Arffman RK, Joenväärä S, Haverinen A, Luiro K, Tohmola T, Renkonen R, Heikinheimo O, Tapanainen JS, Piltonen TT.
    Hum Reprod; 2023 Jan 05; 38(1):89-102. PubMed ID: 36416543
    [Abstract] [Full Text] [Related]

  • 2. Effects of estradiol- and ethinylestradiol-based contraceptives on adrenal steroids: A randomized trial.
    Kangasniemi MH, Arffman RK, Haverinen A, Luiro K, Hustad S, Heikinheimo O, Tapanainen JS, Piltonen TT.
    Contraception; 2022 Dec 05; 116():59-65. PubMed ID: 36084710
    [Abstract] [Full Text] [Related]

  • 3. Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: A randomized clinical trial.
    Haverinen AH, Luiro KM, Szanto T, Kangasniemi MH, Hiltunen L, Sainio S, Piltonen TT, Lassila R, Tapanainen JS, Heikinheimo O.
    Acta Obstet Gynecol Scand; 2022 Oct 05; 101(10):1102-1111. PubMed ID: 35909329
    [Abstract] [Full Text] [Related]

  • 4. Estradiol Valerate in COC Has More Favorable Inflammatory Profile Than Synthetic Ethinyl Estradiol: A Randomized Trial.
    Kangasniemi MH, Haverinen A, Luiro K, Hiltunen JK, Komsi EK, Arffman RK, Heikinheimo O, Tapanainen JS, Piltonen TT.
    J Clin Endocrinol Metab; 2020 Jul 01; 105(7):. PubMed ID: 32303765
    [Abstract] [Full Text] [Related]

  • 5. Estradiol Valerate vs Ethinylestradiol in Combined Oral Contraceptives: Effects on the Pituitary-Ovarian Axis.
    Haverinen A, Luiro K, Kangasniemi MH, Piltonen TT, Hustad S, Heikinheimo O, Tapanainen JS.
    J Clin Endocrinol Metab; 2022 Jun 16; 107(7):e3008-e3017. PubMed ID: 35279718
    [Abstract] [Full Text] [Related]

  • 6. Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study.
    Junge W, Mellinger U, Parke S, Serrani M.
    Clin Drug Investig; 2011 Jun 16; 31(8):573-584. PubMed ID: 21721593
    [Abstract] [Full Text] [Related]

  • 7. Ethinyl estradiol vs estradiol valerate in combined oral contraceptives - Effect on glucose tolerance: A randomized, controlled clinical trial.
    Haverinen A, Kangasniemi M, Luiro K, Piltonen T, Heikinheimo O, Tapanainen JS.
    Contraception; 2021 Jan 16; 103(1):53-59. PubMed ID: 33098852
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols.
    Balkenende EME, Dahhan T, Beerendonk CCM, Fleischer K, Stoop D, Bos AME, Lambalk CB, Schats R, Smeenk JMJ, Louwé LA, Cantineau AEP, de Bruin JP, Linn SC, van der Veen F, van Wely M, Goddijn M.
    Hum Reprod; 2022 Jul 30; 37(8):1786-1794. PubMed ID: 35776109
    [Abstract] [Full Text] [Related]

  • 10. Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
    Klipping C, Duijkers I, Parke S, Mellinger U, Serrani M, Junge W.
    Drugs R D; 2011 Jul 30; 11(2):159-70. PubMed ID: 21679006
    [Abstract] [Full Text] [Related]

  • 11. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
    Ahrendt HJ, Makalová D, Parke S, Mellinger U, Mansour D.
    Contraception; 2009 Nov 30; 80(5):436-44. PubMed ID: 19835717
    [Abstract] [Full Text] [Related]

  • 12. Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
    Davis SR, Bitzer J, Giraldi A, Palacios S, Parke S, Serrani M, Mellinger U, Nappi RE.
    J Sex Med; 2013 Dec 30; 10(12):3069-79. PubMed ID: 24034466
    [Abstract] [Full Text] [Related]

  • 13. Effect of dienogest-containing oral contraceptives on lipid metabolism.
    Wiegratz I, Lee JH, Kutschera E, Bauer HH, von Hayn C, Moore C, Mellinger U, Winkler UH, Gross W, Kuhl H.
    Contraception; 2002 Mar 30; 65(3):223-9. PubMed ID: 11929644
    [Abstract] [Full Text] [Related]

  • 14. ESHRE guideline: endometriosis.
    Becker CM, Bokor A, Heikinheimo O, Horne A, Jansen F, Kiesel L, King K, Kvaskoff M, Nap A, Petersen K, Saridogan E, Tomassetti C, van Hanegem N, Vulliemoz N, Vermeulen N, ESHRE Endometriosis Guideline Group .
    Hum Reprod Open; 2022 Mar 30; 2022(2):hoac009. PubMed ID: 35350465
    [Abstract] [Full Text] [Related]

  • 15. Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3).
    Donnez J, Becker C, Taylor H, Carmona Herrera F, Donnez O, Horne A, Paszkowski M, Petraglia F, Renner SP, Patel A, Boolell M, Bestel E, Dolmans MM.
    Hum Reprod; 2024 Jun 03; 39(6):1208-1221. PubMed ID: 38648863
    [Abstract] [Full Text] [Related]

  • 16. Effect of four different oral contraceptives on various sex hormones and serum-binding globulins.
    Wiegratz I, Kutschera E, Lee JH, Moore C, Mellinger U, Winkler UH, Kuhl H.
    Contraception; 2003 Jan 03; 67(1):25-32. PubMed ID: 12521654
    [Abstract] [Full Text] [Related]

  • 17. Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial.
    Raps M, Rosendaal F, Ballieux B, Rosing J, Thomassen S, Helmerhorst F, van Vliet H.
    J Thromb Haemost; 2013 May 03; 11(5):855-61. PubMed ID: 23410231
    [Abstract] [Full Text] [Related]

  • 18. Impact of estrogen type on cardiovascular safety of combined oral contraceptives.
    Dinger J, Do Minh T, Heinemann K.
    Contraception; 2016 Oct 03; 94(4):328-39. PubMed ID: 27343748
    [Abstract] [Full Text] [Related]

  • 19. 24-hour movement behaviours and cardiometabolic markers in women with polycystic ovary syndrome (PCOS): a compositional data analysis.
    Pesonen E, Farrahi V, Brakenridge CJ, Ollila MM, Morin-Papunen LC, Nurkkala M, Jämsä T, Korpelainen R, Moran LJ, Piltonen TT, Niemelä M.
    Hum Reprod; 2024 Oct 04. PubMed ID: 39366675
    [Abstract] [Full Text] [Related]

  • 20. Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters.
    Wiegratz I, Kutschera E, Lee JH, Moore C, Mellinger U, Winkler UH, Kuhl H.
    Contraception; 2003 May 04; 67(5):361-6. PubMed ID: 12742558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.